Clinical Trial Update: A Study of Anlotinib Hydrochloride Capsules in Subjects With Diffuse Large B-Cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 study evaluating anlotinib hydrochloride capsules in sujets with diffuse large B-cell lymphoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma

Drugs mentioned

• Anlotinib hydrochloride capsules (anlotinib hydrochloride)

Snippet

Sponsor: Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Conditions: Diffuse Large B-cell Lymphoma | Phase 2 | Status: UNKNOWN